Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

Share Price is delayed by 15 minutes
Get Live Data
174.00    0.00 (0.00%)
Bid:
166.00
Ask:
182.00
Spread: 16.00 (9.639%)
Market Cap: £104.96m
JZCP Live PriceLast checked at - London Stock Exchange

Intraday Jz Capital Share Chart

Interim Management Statement

3 Jul 2009 11:51

RNS Number : 0948V
JZ Capital Partners Ltd
03 July 2009
 



JZ CAPITAL PARTNERS LIMITED

(Registration No. 48761)

Registered Office:

2ND FLOOR, REGENCY COURT, GLATEGNY ESPLANADE, ST. PETER PORT,

GUERNSEYGY1 3NQ

___________________________

TELEPHONE: + 44 1481 720321

FACSIMILE: + 44 1481 716117

E-MAIL: JZCP@bfmgl.gg

For immediate release

3 July 2009

Interim Management Statement

3 July 2009

JZ Capital Partners Limited ("JZCP" or the "Company"), a closed ended investment company incorporated in Guernsey whose corporate objective is to create a portfolio of investments in businesses primarily in the United States, announces its Interim Management Statement ("IMS") for the period from 1 March 2009 to 31 May 2009.

Update

On 18 June 2009, the shareholders approved the offerings of 227.6 million Ordinary Shares (at 42 pence per share), the redemption of 29.7 million Zero Dividend Preferred ("ZDP") Shares (at par, or £2.16 per share), the issuance of 4.7 million of new ZDP Shares (at £2.16 per share), a mark to market adjustment for JZCP's forward currency derivative contract, and a 1 for 5 Ordinary Share Consolidation. The effect of these actions on the audited 28 February 2009 balance sheet, assuming an exchange rate for £1.63 for every $1.00, is follows:

(All figures in thousands, except per share data)

Historical

28/2/2009

Ordinary Proceeds

ZDP

Redemption (1)

New

ZDP's Sold

Loss on FX Contract

Estimated Expenses

Pre-

Share Consolidation

Pro Forma 28/2/2009

Post-

Share Consolidation

Pro Forma 28/2/2009

Total Assets

$440,645

$155,791

$(104,355)

$16,530

$(27,256)

$(6,700)

$474,655

$474,655

- Liabilities

(437)

(437)

(437)

- ZDP Shares (2)

(183,224)

(110,386) 

(72,838

(72,838

Net Asset Value ("NAV") (3)

$256,984

$401,380 

$401,380 

Ordinary Shares Outstanding 

97,528

227,565

 

325,093 

65,019 

NAV per Ordinary Share

$2.63

$1.2

$6.17 

(1) Of the 45.7 million ZDP shares that were outstanding prior to the ZDP redemption, 29.7 million ZDP shares were redeemed with the remaining 16.0 million ZDP shares being rolled over.

(2) Historical 28/2/2009 amount includes forward currency derivative contract.

(3) Per JZCP Board.

The data presented below assumes that the actions described above had occurred on 28 February 2009.

Pro Forma Net Asset Value 

For the three months ended 31 May 2009, JZCP's NAV increased by $13.2 million or 3.3%.

28/2/2009

31/5/2009

Net Asset Value ($000's) (1)

$401,380

$414,605

Number of Ordinary Shares (000's)

65,019

65,019

Net Asset Value per Ordinary Share ($)

$6.17

$6.38

(1) Per JZCP Board.

Pro Forma Balance Sheet 

Below is a summary of JZCP's balance sheet as of the relevant dates:

($000's)

28/2/2009

31/5/2009

Cash 

$138,739

$138,386

Listed Equities

47,264

50,572

Listed Debt

28,215

30,798

Private Investments

258,421

266,617

Other Assets (1)

2,016

1,570

Total Assets

$474,655 

$487,943

- Liabilities

(437)

(500)

- Zero Dividend Preferred Shares

(72,838)

(72,838)

Net Asset Value

$401,380

$414,605

 (1) Includes accrued dividends on Listed Equities.

For the three months ending 31 May 2009, our listed equities increased 7.0%. Our listed bank debt, both first and second lien investments, increased by 9.2%, led by a 13.0% increase in first lien loans. Our mezzanine investments increased by 5.7%, while the micro-cap portfolio increased 1.7%. Note that of the 20 mezzanine and micro-cap investments, 18 are current on their interest payments at 31 May 2009.

Portfolio

At 31 May 2009, the Company's investment assets consisted of 44 investments totaling $486.7 million broken out as follows:

Number of Investments

% of Portfolio Valuation 

as of 31/5/09

Micro-Cap Portfolio

 8

33.1%

Cash

28.4%

Mezzanine Investments

12

15.4%

Listed Equity

3

10.5%

Legacy Portfolio

11

6.3%

Bank Debt

10

6.3%

Total Investment Assets

44

100.0%

45.2% of the portfolio is invested in "liquid" assets, which consist of cash, listed equity, and listed debt. These asset classes are valued at third party listed prices. Cash is mainly deposited with HSBC and JPMorgan. 54.8% of the portfolio is invested in private investments in micro-caps or mezzanine investments. These investments are valued at fair value by the JZCP Board of Directors. As a point of reference, the average purchase multiple of the micro-cap investments was 6.0x. The current average enterprise multiple used at 31 May 2009 wa6.0x.

At 31 May 2009, 65.9% of the JZCP investments were valued below cost, and 34.1% were valued at or in excess of cost.

The top ten investments as of 31 May 2009 were as follows:

($000's)

Asset Category

Original Cost

Valuation as of 28/2/2009

% of Portfolio Valuation 

as of 28/2/09

Valuation as of 31/5/2009

% of Portfolio Valuation 

as of 31/5/09

Accutest Holdings, Inc.

Micro-cap

$31,516

$35,947

10.8%

$36,585

10.5%

Safety Insurance Group, Inc.

Listed Equity

6,816

36,218

10.9%

36,276

10.4%

Continental Cement Company, LLC 

Mezzanine

20,660

20,990

6.3%

24,595

7.1%

Dental Services Group, Inc.

Micro-cap

19,854

24,093

7.2%

24,164

6.9%

BG Holdings, Inc. 

Micro-cap

21,332

19,819

5.9%

21,629

6.2%

Wound Care Solutions, LLC

Micro-cap

39,595

19,628

5.9%

19,976

5.7%

Petco Animal Supplies, Inc.

Listed Debt / Mezzanine

19,463

19,575

5.9%

19,773

5.7%

Dantom Systems, Inc.

Micro-cap

18,716

18,432

5.5%

18,659

5.4%

GHW Holdings, Inc.

Micro-cap

7,467

15,367

4.6%

15,351

4.4%

Sechrist Industries, Inc.

Micro-cap

5,829

14,553

4.4%

14,516

4.2%

Top Ten Investments

$191,248

$224,622

67.4%

$231,524

66.5%

Remaining Investments

196,579

109,278

32.6%

116,796

33.5%

Total Portfolio

$387,827

$333,900

100.0%

$348,320

100.0%

The portfolio is diversified across the following business sectors:

Number of Companies

% of Portfolio Valuation 

as of 31/5/09

Health Care Equipment & Services

7

27.9%

Support Services

10

22.5%

House, Leisure & Personal Goods

6

12.3%

Financial General

4

10.8%

Industrial Engineering

7

8.6%

Construction Materials

4

11.7%

Other

6

6.2%

Total Portfolio

44

100.0%

Material Events and Transactions

In the three months endin31 May 2009:

The Company invested $1.5 million of additional preferred stock in BG Holdings, Inc. to support certain capital purchases.

The Company invested $2.8 million of Senior Subordinated Notes in Continental Cement Company, LLC.

The Company recorded a $17.1 million loss on a forward currency derivative contract.

About JZCP

JZCP is a closed ended investment company incorporated in Guernsey. The Company's corporate objective is to create a portfolio of investments in businesses primarily in the United States providing a superior overall return comprised of a current yield and significant capital appreciation. The Company's strategies include investments in micro-cap buyouts, mezzanine loans (sometimes with equity participations) and high yield securities, senior secured debt and second lien loans and other debt and equity opportunities. The Company's Ordinary Shares and Zero Dividend Preferred Shares are listed on the London Stock Exchange.

Enquiries

Company Secretary

Butterfield Fulcrum Group (Guernsey) Limited

2nd Floor, Regency Court

Glategny Esplanade

St Peter Port

Guernsey

GY1 3NQ

 

Tel. +44 1481 720321

Fax. +44 1481 716117

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUUUBCMUPBGUW
Date   Source Headline
21st Jun 201112:44 pmRNSNet Asset Value(s)
21st Jun 20117:00 amRNSInterim Management Statement
26th May 20118:10 amRNSNet Asset Value(s)
24th May 20116:01 pmRNSNotice of AGM
12th May 20118:53 amRNSNet Asset Value(s)
9th May 20113:36 pmRNSDividend Declaration
9th May 20117:00 amRNSAnnual Results for Period Ending 28 February 2011
3rd May 20112:26 pmRNSNotice of Results
13th Apr 20118:33 amRNSNet Asset Value(s)
31st Mar 20113:46 pmRNSTotal Voting Rights
15th Mar 20115:07 pmRNSCapital Reorganisation
16th Feb 201110:24 amRNSNet Asset Value(s)
21st Jan 20119:02 amRNSNet Asset Value(s)
23rd Dec 201012:26 pmRNSResult of EGM
21st Dec 20104:26 pmRNSNet Asset Value(s)
21st Dec 20107:00 amRNSInterim Management Statement
14th Dec 201010:38 amRNSDisposal
9th Dec 201010:36 amRNSHolding(s) in Company
30th Nov 20107:00 amRNSEurope Fund arrangements, Fund A Documents
22nd Nov 20108:37 amRNSNet Asset Value(s)
28th Oct 20103:45 pmRNSNet Asset Value(s)
28th Oct 20107:00 amRNSHalf Yearly Report
6th Oct 20106:20 pmRNSDirector Declaration
17th Sep 20109:00 amRNSNet Asset Value(s)
19th Aug 20109:30 amRNSNet Asset Value(s)
27th Jul 20103:30 pmRNSNet Asset Value(s)
12th Jul 201011:28 amRNSDirector Declaration
22nd Jun 20102:00 pmRNSNet Asset Value(s)
22nd Jun 20107:00 amRNSInterim Management Statement
22nd Jun 20107:00 amRNSResult of AGM
28th May 20103:45 pmRNSNet Asset Value(s)
19th May 20108:45 amRNSNet Asset Value(s)
18th May 20107:00 amRNSFinal Results
13th May 201011:02 amRNSNotice of Results
30th Mar 201011:30 amRNSNet Asset Value(s)
4th Mar 20107:00 amRNSDividend Declaration
1st Mar 201010:00 amRNSNet Asset Value(s)
10th Feb 201010:00 amRNSNet Asset Value(s)
21st Dec 200911:30 amRNSNet Asset Value(s)
21st Dec 20097:00 amRNSInterim Management Statement
20th Nov 200910:30 amRNSNet Asset Value(s)
30th Oct 20092:00 pmRNSNet Asset Value(s)
30th Oct 20097:00 amRNSInterim Results
6th Oct 200910:00 amRNSNet Asset Value(s)
20th Aug 20093:58 pmRNSNet Asset Value(s)
3rd Aug 20092:03 pmRNSNet Asset Value(s)
16th Jul 20092:45 pmRNSResult of AGM
3rd Jul 200911:51 amRNSInterim Management Statement
2nd Jul 20096:12 pmRNSHolding(s) in Company
30th Jun 20094:07 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.